Related Experiment Videos
[CBO guideline 'Osteoporosis' (second revision].
1Erasmus Medisch Centrum Rotterdam, locatie Dijkzigt, afd. Inwendige Geneeskunde, Rotterdam.
Nederlands Tijdschrift Voor Geneeskunde
|August 7, 2002
Summary
Osteoporotic fracture risk factors include previous fractures, family history, and corticosteroid use. Bone mineral density (BMD) testing is recommended for specific individuals, not general screening.
Area of Science:
- Endocrinology and Bone Metabolism
- Geriatrics
- Public Health
Context:
- Osteoporotic fractures pose a significant health burden, particularly in aging populations.
- Current Dutch guidelines (CBO) provide a framework for identifying individuals at risk.
- Bone mineral density (BMD) measurement plays a role in targeted case-finding.
Purpose:
- To outline current guidelines for identifying individuals at risk of osteoporotic fractures.
- To define criteria for bone mineral density (BMD) testing and supplementation.
- To provide recommendations for pharmacologic treatment of osteoporosis.
Summary:
- Key risk factors for osteoporotic fractures include prior fractures, positive family history, low body weight, immobility, and corticosteroid use.
- BMD testing is advised for specific patient groups, not for broad population screening.
- Calcium and Vitamin D supplementation are recommended for at-risk individuals, and pharmacologic treatments like bisphosphonates are indicated for established osteoporosis or high-risk corticosteroid users.
Impact:
- Facilitates early identification and intervention for individuals at high risk of osteoporotic fractures.
- Optimizes the use of BMD testing and supplementation strategies.
- Guides appropriate pharmacologic management to prevent fractures and improve patient outcomes.